224 related articles for article (PubMed ID: 8838251)
1. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
[TBL] [Abstract][Full Text] [Related]
2. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
Dawson JE; Raymond AM; Winn LM
Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
[TBL] [Abstract][Full Text] [Related]
3. Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice.
Spiegelstein O; Merriweather MY; Wicker NJ; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):974-8. PubMed ID: 14745917
[TBL] [Abstract][Full Text] [Related]
4. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
[TBL] [Abstract][Full Text] [Related]
5. Influence of maternal folate status on the developmental toxicity of methanol in the CD-1 mouse.
Sakanashi TM; Rogers JM; Fu SS; Connelly LE; Keen CL
Teratology; 1996 Oct; 54(4):198-206. PubMed ID: 9122889
[TBL] [Abstract][Full Text] [Related]
6. Lack of attenuation of valproic acid-induced effects by folinic acid in rat embryos in vitro.
Hansen DK; Grafton TF
Teratology; 1991 Jun; 43(6):575-82. PubMed ID: 1882348
[TBL] [Abstract][Full Text] [Related]
7. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
Padmanabhan R; Hameed MS
J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
[TBL] [Abstract][Full Text] [Related]
8. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione.
Hishida R; Nau H
Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
10. The effects of periconceptional folic acid and vitamin supplementation on maternal folate levels and on neurulating hamster embryos in vivo.
Mooij PN; Thomas CM; Doesburg WH; Eskes TK
Int J Vitam Nutr Res; 1993; 63(3):212-6. PubMed ID: 8300333
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid-induced spina bifida: a mouse model.
Ehlers K; Stürje H; Merker HJ; Nau H
Teratology; 1992 Feb; 45(2):145-54. PubMed ID: 1377411
[TBL] [Abstract][Full Text] [Related]
12. Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse.
Nau H
Teratology; 1986 Feb; 33(1):21-7. PubMed ID: 3090732
[TBL] [Abstract][Full Text] [Related]
13. Multiple point action mechanism of valproic acid-teratogenicity alleviated by folic acid, vitamin C, and N-acetylcysteine in chicken embryo model.
Hsieh CL; Wang HE; Tsai WJ; Peng CC; Peng RY
Toxicology; 2012 Jan; 291(1-3):32-42. PubMed ID: 22051200
[TBL] [Abstract][Full Text] [Related]
14. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
Massa V; Wlodarczyk B; Giavini E; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
[TBL] [Abstract][Full Text] [Related]
15. Spina bifida aperta induced by valproic acid and by all-trans-retinoic acid in the mouse: distinct differences in morphology and periods of sensitivity.
Ehlers K; Stürje H; Merker HJ; Nau H
Teratology; 1992 Aug; 46(2):117-30. PubMed ID: 1440416
[TBL] [Abstract][Full Text] [Related]
16. Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
Okada A; Kurihara H; Aoki Y; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
Padmanabhan R; Shafiullah MM
Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
[TBL] [Abstract][Full Text] [Related]
18. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
Sato M; Shirota M; Nagao T
Teratology; 1995 Sep; 52(3):143-8. PubMed ID: 8638254
[TBL] [Abstract][Full Text] [Related]
19. Methionine reduces the valproic acid-induced spina bifida rate in mice without altering valproic acid kinetics.
Ehlers K; Elmazar MM; Nau H
J Nutr; 1996 Jan; 126(1):67-75. PubMed ID: 8558327
[TBL] [Abstract][Full Text] [Related]
20. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
Gravemann U; Volland J; Nau H
Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
